CAPECITABINE (CAPE) +/- BEVACIZUMAB (BEV) IN THE ADJUVANT TREATMENT OF COLORECTAL CANCER (CRC) FIRST AND FINAL TOXICITY RESULTS FROM THE INTERNATIONAL PHASE III QUASAR2 TRIAL - Midgley, R; Love, S; Potter, V; Segelov, E; Ferry, DR; Weaver, A; Scudder, C; Julier, P; Grumett, S; Kerr, D (2012)